PIK3CA and colorectal cancer: Although aspirin is primarily used as an antipyretic and analgesic drug, many studies have shown that aspirin can effectively prolong the survival of colorectal cancer patients with PIK3CA mutations (Zumwalt et al. 2017; Domingo et al. 2013).